Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy-Reference-Cited by-同舟云学术

Autologous-cancer-cryoablation-mediated nanovaccine augments systematic immunotherapy

Author:

Yu Zhongyang¹²,Wang Dawei³⁴,Qi Yuxia¹²,Liu Jing³⁴,Zhou Tian²,Rao Wei³⁴^ORCID,Hu Kaiwen²

Affiliation:

1. Graduate School, Beijing University of Chinese Medicine, Beijing, 100029, China

2. Oncology Department, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, 100078, China

3. Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, China

4. School of Future Technology, University of Chinese Academy of Sciences, Beijing 100049, China

Abstract

Cancer vaccines developed from autologous tumors after cryoablation holds tremendous promise for individualized cancer immunotherapy.

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Electrical and Electronic Engineering,Process Chemistry and Technology,Mechanics of Materials,General Materials Science

Link

Reference44 articles.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献